Photodynamic therapy (PDT) is an effective treatment for easily accessible tumors such as oral and skin cancer
But the procedure, which uses lasers to activate special drugs called photosensitizing agents, isn’t adept at fighting cancer deep inside the body. Thankfully, that’s changing due to new technology that could bring PDT into areas of the body which were previously inaccessible.
Described May 11 in the journal Nature Photonics, the approach involves using near-infrared beams of light that, upon penetrating deep into the body, are converted into visible light that activates the drug and destroys the tumor.
“We expect this will vastly expand the applications for an effective cancer phototherapy that’s already in use,” said co-author Tymish Ohulchanskyy, PhD, University at Buffalo research associate professor and deputy director for photomedicine at the university’s Institute for Lasers, Photonics and Biophotonics (ILPB).
Doctors have used PDT to treat cancer for decades. Cancer cells absorb the drug, which is delivered to the tumor via the bloodstream or locally. Visible light is then applied to the site, which causes the drug to react with oxygen and create a burst of free radicals that kill the tumor.
Unfortunately, visible light does not penetrate tissue well. Conversely, near-infrared light penetrates tissue well but doesn’t activate the drugs efficiently.
To solve this problem, some researchers are developing drugs that absorb near-infrared light. This method is limited, however, because stable and efficient near-infrared absorbing photosenzitizers are notoriously difficult to synthesize.
The UB-led team took a different approach, which uses the tumor’s natural environment to tune the light into the necessary wavelengths.
For example, the near-infrared laser beam interacts with the natural protein collagen, which is found in connective tissues. The interaction changes the near-infrared light to visible light, a process known as second harmonic generation. Likewise, natural proteins and lipids within the cells interact with near-infrared laser light and change it to visible light through another process called four-wave mixing.
Thus, visible light can be generated in tumors deep inside the body, and it can be absorbed by the drug. This activates the drug, which then destroys the tumor.
The procedure has numerous advantages, said the study’s leader, Paras Prasad, PhD, SUNY Distinguished Professor in chemistry, physics, electrical engineering, and medicine at UB, and the ILPB’s executive director.
“There are no long-term side effects for PDT, it’s less invasive than surgery, and we can very precisely target cancer cells,” he said. “With our approach, PDT is enriched to provide another tool that doctors can use to alleviate the pain of millions of people suffering from cancer.”
The Latest on: Light-based cancer treatment
[google_news title=”” keyword=”Light-based cancer treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Light-based cancer treatment
- Researchers shed light on increased risk of second cancers among breast cancer survivorson April 25, 2024 at 11:32 am
Breast cancer survivors have a much greater chance of having secondary cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research based on data ...
- New Alzheimer’s Treatment Uses Light & X-Rays To Hit Harmful Proteinon April 24, 2024 at 1:35 am
A new treatment for early-stage Alzheimer’s uses nanoparticles and light to slow the progress of the disease, set off by a low-powered x-ray.
- Targeting mouth cancer with light-activated drugson April 23, 2024 at 12:29 pm
LightOx explained how light-activated drugs can be used to treat cancer on day one of the Biotrinity 2024 conference in London.
- Non-invasive light-based techniques may improve detection of skin cancer, reveals studyon April 19, 2024 at 9:30 am
A study conducted by Aston University researchers has demonstrated that the appearance of ageing skin looks noticeably different compared to younger skin, when examined under polarised laser ...
- Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Studyon April 18, 2024 at 1:22 pm
In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
- Many With Breast Cancer 'Systematically Left Behind,' Report Sayson April 15, 2024 at 3:33 pm
Commission members noted that despite progress in research and cancer management that has substantially decreased breast cancer mortality in high-income countries, the World Health Organization still ...
- Metastatic Breast Cancer Diagnosis and Treatment-Response Monitoringon April 10, 2024 at 6:57 am
Learn about the tests and procedures doctors use to find metastatic breast cancer and then make sure treatment is working.
- King Charles Has Surprise Walkabout After Sitting Apart from Royal Family at Easter Service amid Treatmenton March 30, 2024 at 5:01 pm
Based on medical advice ... expected to be scaled down. In light of his cancer treatment, doctors have advised the King to minimize contact with others, as announced by the palace on February ...
- Scientists use AI to identify new aggressive prostate cancer typeon March 2, 2024 at 7:33 am
This discovery is poised to revolutionize the diagnosis and treatment ... of prostate cancer samples across nine countries, the researchers identified these genotypes, shedding light on the ...
- Prostate Cancer Newson February 12, 2024 at 4:00 pm
18, 2024 — Researchers have developed a new urine-based test ... New research sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that ...
via Bing News